MEDICAL PROPERTIES TRUST INC. STOCK ALERT: Don’t Miss the Lead Plaintiff Deadline in the MPW Class Action Stay Informed and Protect Your Investments Investing in the stock market can be a rollercoaster of ups and downs. It’s important to stay informed and be aware of any potential risks. That’s why Robbins LLP is reminding investors…
The Controversial Subpoena: A Politically Charged Battle House Oversight Committee Chair James Comer’s Subpoena House Oversight Committee Chair James Comer (R-KY) is moving ahead with a subpoena against Los Angeles-based real estate investor Elizabeth Hirsch Naftali, who purchased art from Hunter Biden — despite the fact that Naftali is currently dealing with her three-year-old niece…
Federal Home Loan Bank of San Francisco’s Teresa Bryce Bazemore Receives 2023 Financial Woman of the Year Award: A Reflection on Her Professional and Leadership Journey Description: Teresa Bryce Bazemore is Financial Women of San Francisco’s 2023 Financial Woman of the Year. SAN FRANCISCO, Nov. 09, 2023 (GLOBE NEWSWIRE) — Teresa Bryce Bazemore, president and…
Exciting Times Ahead for Aussie Accountants! What’s New with CCH iFirm? So, have you heard the news? Wolters Kluwer Tax & Accounting (TAA) Asia Pacific (APAC) has just unveiled some game-changing updates for Australian users of CCH iFirm. This cloud-based platform just got a whole lot more powerful, with new capabilities and deeper integrations that…
DeSantis Debunked: Florida Governor’s Claims Against Student Groups Proven False Setting the Record Straight on DeSantis’ False Claims Among the claims made in Wednesday’s debate came from Florida Gov. Ron DeSantis (R), who touted his quick action in defense of Israel. “I already acted in Florida,” DeSantis claimed. “We deactivated them. We’re not going to…
My Office Got Vandalized and It’s Not Even Friday the 13th! It’s All Fun and Games Until Someone Writes “Monica Murders” on Your Door What Happened? So, imagine my surprise when I walked into my District 15 office in McAllen, Texas, this week to find it covered in messages criticizing my stance on the Israel-Hamas…
Exciting FDA Approval for Adzynma What is Adzynma? Adzynma is the first recombinant protein product approved by the U.S. Food and Drug Administration for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP). This rare and life-threatening blood clotting disorder can now be managed with this groundbreaking enzyme replacement therapy. How Does Adzynma Work? Adzynma is…
Welcome to the Future of Primary Care Groundbreaking Event Hosted by AJMC In partnership with Optum and Independent Physicians Network, the American Journal of Managed Care’s Institute for Value-Based Medicine is hosting an event that is set to revolutionize the way we approach primary care in the healthcare industry. The event, titled “Building the Primary…
